Treatment for Breast Cancer in Patients with Alzheimer's Disease
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objectives: To report use of breast cancer treatment (surgery, radiation, and chemotherapy) by patients with Alzheimer's disease (AD). Design: Retrospective cohort study. Setting: Surveillance, Epidemiology, and End Results (SEER) is a population‐based cancer registry covering 14% of the U.S. population. Participants: Fifty thousand four hundred sixty breast cancer patients aged 65 and older, of whom 1,935 (3.8%) had a diagnosis of AD before or up to 6 months after cancer diagnosis. Measurements: Diagnosis of AD was taken from International Classification of Diseases, Ninth Revision , diagnostic codes accompanying Medicare billing claims between 1992 and 1999. The SEER program reported surgery and radiation. Chemotherapy was taken from Medicare billing records. Results: Subjects with AD were diagnosed with breast cancer at later stages, when tumors were larger and the likelihood of lymph node involvement had increased. Patients with AD had a lower likelihood of surgery (odds ratio (OR)=0.60, 95% confidence interval (CI)=0.46–0.81), radiation (OR=0.31, 95% CI=0.23–0.41), and chemotherapy (OR=0.44, 95% CI=0.34–0.58) than those without AD. Conclusion: Overall, AD patients receive less treatment for breast cancer than do comparable female Medicare beneficiaries. Chemotherapy and radiation are administered less frequently to women with AD than to other comparable patients. It is unclear whether suboptimal medical care has an effect on their survival. Further research on the effect of screening and treatment decision‐making for these patients is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comorbidity measures for use with administrative data.
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998) · Medical Care · doi:10.1097/00005650-199801000-00004 · Cited by 9,921 · cited 1×
“Using the Deyo-Charlson comorbidity index.(21) 1900 GORIN ET AL.”
MethodKrieger, N., Chen, J. T., Waterman, P. D., Rehkopf, D. H., & Subramanian, S. V. (2003) · American Journal of Public Health · doi:10.2105/ajph.93.10.1655 · Cited by 711 · cited 1×
“Census-tract level percentage below poverty is considered a reasonable and useful measure of economic deprivation.(18) Urban residence was defined as largest metropolitan (41 million population), metropolitan (250,000–1 million), urban (20,000–250,000), less urban (2,500–20,000), and rural areas (o2,500 per county), f…”
BackgroundEvans, D. A., Bennett, D. A., Wilson, R. S., Bienias, J. L., Morris, M. C., Scherr, P. A., Hebert, L. E., Aggarwal, N., Beckett, L. A., Joglekar, R., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.185 · Cited by 370 · cited 3×
“The clinical etiologies of dementia are thought to differ between African Americans and Caucasian Americans,(34) although there may be a higher prevalence of AD in African Americans, a finding that has been reported in population-based(35) and community studies.(36,37) The racial difference in incidence may be due to…”
BackgroundMethodPredicting Time to Nursing Home Care and Death in Individuals With Alzheimer Disease
Stern, Y. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340040030 · Cited by 359 · cited 1×
“Although stage is a strong and consistent predictor of breast cancer prognosis,(44) expected length of life for patients with AD can be highly variable, depending on age at diagnosis with AD, sex, and symptomatology.(45) Using these databases, it is not possible to measure the influence of physicians’ own estimations…”
Background
Cited by
Mohile, S. G., Dale, W., Somerfield, M. R., Schonberg, M. A., Boyd, C. M., Burhenn, P. S., Canin, B., Cohen, H. J., Holmes, H. M., Hopkins, J. O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8687 · Cited by 1,479
Comprehensive geriatric assessment for older patients with cancer
Extermann, M., & Hurria, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6559 · Cited by 875
The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
Taylor, Jr., Østbye, T., Langa, K. M., Weir, D., & Plassman, B. L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1099 · Cited by 354
“When analysts use Medicare claims records to identify dementia, they are often interested in the effect of dementia on the cost to the Medicare program [10– 12 , 18 ].”
An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status
Janelsins, M. C., Kohli, S., Mohile, S. G., Usuki, K., Ahles, T. A., & Morrow, G. R. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.03.014 · Cited by 342
Delays in Breast Cancer Diagnosis and Treatment by Racial/Ethnic Group
Gorin, S. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.20.2244 · Cited by 294
Self-citation
Metadata
- Authors
- Gorin, S. S., Heck, J. E., Albert, S., & Hershman, D.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2005-09-23
- Volume
- 53
- Issue
- 11
- Pages
- 1897-1904
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W1525675742
- Cited by
- 109
- References
- 4
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment for Breast Cancer in Patients with Alzheimer's Disease. https://app.cochat.ai/papers/10.1111/j.1532-5415.2005.00467.x
- The paper
- Gorin, S. S., Heck, J. E., Albert, S., & Hershman, D. (2005). Treatment for Breast Cancer in Patients with Alzheimer's Disease. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2005.00467.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.